Abstract
Inflammation and neuronal degeneration of the substantia nigra (SN) occur in Parkinson's disease (PD). We studied the effects of intranigral lipopolysaccharide (LPS) injection on adult Sprague-Dawley rats. Locomotor activity measurement, neurotransmitter determination and perfusion fixation for immunohistochemistry were done on the 7th day. Bilateral LPS injection increased locomotor activity 2- to 3-fold. In the SN, dopamine (DA) and serotonin (5-HT) decreased but the ratios dihydroxyphenylacetic acid (DOPAC)/DA, homovanillic acid (HVA)/DA and 5-hydroxyindole-acetic acid (5-HIAA)/5-HT increased. In the striatum, DA, DOPAC, HVA, 3-methoxytyramine and epinephrine decreased but HVA/DA and 5-HIAA/5HT ratios increased. Unilateral LPS decreased dopamineric neurons ipsilaterally but increased contralaterally. This study provides the first evidence of behavioral hyperactivity, epinephrine suppression and neuronal plasticity in the LPS model of PD.
References
Sep 1, 1992·Neuroreport·L G ChiaE H Lee
Feb 1, 1992·Molecular and Chemical Neuropathology·K Kristensson
Sep 1, 1990·Neuroreport·B CostallR J Naylor
Jan 1, 1990·Neuroscience·L J LawsonS Gordon
Jul 1, 1990·Neurotoxicology and Teratology·V A ColotlaR Tapia
Sep 18, 1989·Brain Research·D M YurekJ R Sladek
Jan 1, 1985·Neuropharmacology·F HeftiE Melamed
Oct 1, 1988·Annals of Neurology·P L McGeerE G McGeer
Aug 1, 1988·Neurology·P L McGeerE G McGeer
Mar 22, 1974·Brain Research·D S Segal, R Kuczenski
Mar 1, 1974·Brain : a Journal of Neurology·S LockeJ Hilsz
May 18, 1984·European Journal of Pharmacology·A EnzW Frick
Jan 1, 1995·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M MogiT Nagatsu
Oct 24, 1994·Neuroscience Letters·M MogiT Nagatsu
Nov 1, 1994·Neuroscience·Y Amitai
May 19, 1994·Neuroscience Letters·G BokaE C Hirsch
Dec 15, 1995·Brain Research·D M BronsteinM K McMillian
Sep 1, 1996·Neuroscience·R WangL E Limbird
Oct 25, 1996·Neuroscience Letters·L G ChiaG Dryhurst
Nov 4, 1996·Neuroreport·B KriemJ H Abraini
Jan 20, 1997·Neuroreport·M G EspeyC A Colton
May 14, 1998·Neuroreport·H PyoE H Joe
May 15, 1998·Journal of Neurochemistry·A CastañoA Machado
Jun 29, 1999·Glia·S F TzengJ De Vellis
Jan 29, 2000·Brain : a Journal of Neurology·G M JacksonL Dow
Mar 10, 2000·Brain Research·A SuwabeS Kanba
May 9, 2000·Neuroscience·X LuT Hagg
Citations
Sep 29, 2011·Neurotoxicity Research·Camila G MoreiraMarcelo M S Lima
Apr 23, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Marie-Francoise DoursoutRoger J Bick
May 9, 2009·PloS One·Dong-Young ChoiGuoying Bing
May 24, 2011·Parkinson's Disease·Mei Liu, Guoying Bing
Mar 13, 2014·Journal of Neuroinflammation·Rong-Pei LiuJian-Hong Zhu
Jun 29, 2010·Neurochemical Research·Deborah ArizaMaria A B F Vital
Oct 10, 2012·Brain, Behavior, and Immunity·Deirdre B HobanEilis Dowd
Aug 25, 2005·Journal of Neuroscience Research·Lir-Wan FanZhengwei Cai
Jul 28, 2005·The European Journal of Neuroscience·Mahmoud M IravaniPeter Jenner
Feb 19, 2009·Journal of Neuroscience Research·Randy L HunterGuoying Bing
Sep 3, 2003·Journal of Neurochemistry·Yi HeWeidong Le
Jan 27, 2007·Journal of Neurochemistry·Randy L HunterGuoying Bing
Jun 9, 2007·Journal of Neurochemistry·Sriram VennetiClayton A Wiley
Jan 8, 2009·Annals of Neurology·Peter Jenner
Aug 3, 2013·Journal of Neuroscience Research·Ana Carolina D Dos SantosMarcelo M S Lima
Sep 8, 2005·Brain Research Bulletin·J Gunasingh MasilamoniR Jayakumar
Sep 3, 2013·Pharmacology, Biochemistry, and Behavior·Ekaterina Yu BazhenovaNina K Popova
Jan 9, 2014·Behavioural Brain Research·Shirin BabriAli-Akbar Salari
May 29, 2015·PloS One·Ashham MansurJosé Hinz
Jun 27, 2003·Environmental Health Perspectives·Bin LiuJau-Shyong Hong
Aug 23, 2019·Biomolecules·Jayden A O'Brien, Paul J Austin
May 10, 2019·Psychopharmacology·Ilya D IonovLarissa A Shpilevaya
May 19, 2021·Psychopharmacology·Ilya D IonovNicholas N Severtsev
Nov 11, 2010·Science Signaling·Joseph Mathew Antony